Ref ID: 19284
Author:
S. Park, C. Jimenez-Ortigosa, G. Delmas, E. Dolgov, I. Kolesnikova, Y. Senin, D. S. Perlin
Author address:
Publ. Hlth. Res. Inst., Newark, NJ.
Full conference title:
53rd Interscience Conference on Antimicrobial Agents and Chemotherapy
Date: 10 September 2014
Abstract:
Background: FKS mutations alter the sensitivity of glucan synthase for echinocandin drugs in Candidaspp. and have been linked to clinical failures. All fks mutations increase MIC values but not all mutations have the potential for adverse clinical outcome. To better understand the potential clinical significance of these mutations, a neutropenic murine kidney burden model was used as a surrogate to assess the relationship between specific fks mutations. Six well-characterized clinical isolates of Candida glabratadisplaying a broad spectrum of fks mutations displaying low to moderate micafungin (MFG) MIC values (0.06 to 0.5 mg/L) were evaluated in this model. Methods: A neutropenic murine candidiasis model was used to establish the MFG Effective Doses. Mice were rendered neutropenic by cytoxan injection and i.v. infected with C. glabrata. Daily treatments of PBS, 0.05, 0.5, 5.0, or 50 mg/kg of MFG starting at 3 h post infection for up to 4 days. A susceptible strain ATCC 90030 was used as a comparator in all studies. A Non-linear regression analysis was performed using Graphpad Prism 5.0 software to calculate 99% effective doses (ED99). Echinocandin susceptibility testing was performed following CLSI method M27-A3. Results: MFG ED99 values of the C. glabrata fks mutants ranged from 3.1 to 36.2 mg/kg/qd or ~11 to 125 times higher than the susceptible strain ATCC 90030 (0.3 mg/kg/qd). The ED99 values for four out of the
six fks mutants were only 11-25 fold greater than ATCC
90030 and all mutants responded well to escalating MFG
doses. The fks mutant strains DPL 42 (Fks1p D632) and
DPL 236 (Fks2p L664) displayed the highest ED99 values at
125 and 88 times higher than ATCC 90030, respectively. Conclusions: The ED99 data of these FKS mutants suggest
that the precise nature of the fks genotype is a better
predictor of echinocandin resistance. These mutations have
lower frequencies of clinical resistance indicating that C.
glabrata fks genotype ranking for clinical resistance may be
distinct from other clinically important Candida spp.
Abstract Number: NULL
Conference Year: 2013
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a